Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol in Sturge-Weber Syndrome
NCT02332655Phase 2Completed
- Start
- Dec 2014
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabidiol in Sturge-Weber syndrome (SWS). Started Dec 2014; status: completed.
02
Drugs
cannabidiol
03
Conditions
Sturge-Weber syndrome (SWS)
Beyond the preview
Go deeper on NCT02332655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02332655.